top of page
IMMUNOLOGY& RARE DISEASE
INFUSION THERAPIES
Personalized infusion therapies delivered in a private, physician-directed setting.
MEDICATION
Privigen®
CONDITIONS
Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy
Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Multifocal Motor Neuropathy
Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Immune Thrombocytopenia
VISIT TIME
FREQUENCY
2-6 Hours
Every 3-4 Weeks
Gammagard Liquid®
2-6 Hours
Every 3-4 Weeks
Gamunex-C®
2-6 Hours
Every 3-4 Weeks
Panzyga®
Primary Immunodeficiency
2-5 Hours
Every 3-4 Weeks
Fabrazyme®
Fabry Disease
3-5 Hours
Every 2 Weeks
Lumizyme®
Pompe Diseae
4-6 Hours
Every 2 Weeks
Cerezyme®
Gaucher Disease
1-2 Hours
Every 2 weeks
Alpha-1 Antitrpsin Deficiency
Glassier®
1 Hour
Weekly
FDA-approved therapies used to treat autoimmune and inflammatory conditions.
FDA-approved therapies used to treat autoimmune and inflammatory conditions.
Therapy selection, dosing, schedules, and visit times are determined solely by your prescribing physician based on your individual diagnosis, medical history, response to treatment, and current prescribing information. Infusion times and schedules listed are general approximations based on manufacture guidelines and may vary by patient, protocol, or clinical procedures. AURA Infusions does not prescribe or select therapies. Â
Therapy selection, dosing, schedules, and visit times are determined solely by your prescribing physician based on your individual diagnosis, medical history, response to treatment, and current prescribing information. Infusion times and schedules listed are general approximations based on manufacture guidelines and may vary by patient, protocol, or clinical procedures. AURA Infusions does not prescribe or select therapies. Â
bottom of page